Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia
Tarih
2014Yazar
KIYKIM, AHMET ALPER
UYANIK, Abdullah
Unsal, Abdulkadir
Sezer, Siren
ÇAMSARI, TANER
Cirit, Mustafa
Duman, Neval
Ozdener, Fatih
Sindel, Sukru
YENİÇERİOĞLU, YAVUZ
Akbas, Ertugrul
YILMAZ, MEHMET EMİN
ALTUN, BÜLENT
Duranay, Murat
Yildiz, Alaattin
ŞAHİN, İDRİS
DOĞUKAN, AYHAN
ÜSTÜNDAĞ, SEDAT
KARAYAYLALI, İBRAHİM
VELİOĞLU, ARZU
Üst veri
Tüm öğe kaydını gösterÖzet
Background. This study was conducted to evaluate the efficacy and safety of once-monthly continuous erythropoietin receptor activator (CERA) for maintenance of stable haemoglobin (Hb) levels in adult chronic renal anaemia patients on dialysis according to local clinical judgment in Turkey.
Koleksiyonlar
- Makale [92796]